vixarelimab

Roche, Genentech sign license deal with Kiniksa for vixarelimab
Pharmaceutical Business Review
Thu, 08/4/22 - 10:54 am
Kiniksa Pharmaceuticals
Roche
Genentech
vixarelimab
monoclonal antibodies